Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Exploring the Role of Unfolded Protein Response in HIV-1 Replication and Infectivity
Published on: June 14, 2024
PRL-3 mediates the protein maturation of ULBP2 by regulating the tyrosine phosphorylation of HSP60
Wai-Hang Leung1, Queenie P Vong1, Wenwei Lin2
1Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN 38105;
Abstract:
Many malignant cells release the NKG2D ligand ULBP2 from their cell surface to evade immunosurveillance by NK cells and CD8 T cells. Although the shedding mechanism remains unclear, various inhibitors of matrix metalloproteinases have been shown to efficiently block the release of soluble ULBP2. The clinical use of these inhibitors, however, is limited because of adverse side effects. Using high-throughput screening technique, we identified a specific inhibitor of phosphatase of regenerating liver 3 (PRL-3) that could reduce the level of soluble ULBP2 in the culture supernatant of various cancer cell lines. Inhibition or gene knockdown of PRL-3 did not reduce ULBP2 shedding, but rather suppressed posttranslational maturation of ULBP2, resulting in intracellular retention of immature ULBP2. We then found that ULBP2 was constitutively associated with heat shock protein HSP60. Complete maturation of ULBP2 required tyrosine phosphorylation of HSP60 which was mediated by PRL-3.
Insights
Malignant cells evade immune cells by releasing ULBP2. A novel inhibitor targeting PRL-3 blocks ULBP2 maturation, not shedding, offering a new therapeutic strategy against cancer immune evasion.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Malignant cells release NKG2D ligand ULBP2 to evade NK and CD8 T cell immunosurveillance.
- Current methods to block ULBP2 shedding, like metalloproteinase inhibitors, have limitations due to side effects.
Purpose of the Study:
- To identify novel therapeutic targets for blocking ULBP2 release.
- To investigate the mechanism by which PRL-3 affects ULBP2 levels.
Main Methods:
- High-throughput screening to identify PRL-3 inhibitors.
- Cancer cell line culture and supernatant analysis.
- Gene knockdown experiments and Western blotting for ULBP2 and HSP60.
Main Results:
- A specific PRL-3 inhibitor reduced soluble ULBP2 levels in cancer cell lines.
- PRL-3 inhibition or knockdown suppressed ULBP2 posttranslational maturation, causing intracellular retention.
- ULBP2 maturation depends on PRL-3-mediated tyrosine phosphorylation of HSP60.
Conclusions:
- PRL-3 plays a critical role in ULBP2 maturation, not shedding.
- Targeting PRL-3 offers a potential strategy to enhance anti-tumor immunity by preventing ULBP2 maturation.
Related Concept Videos
The Unfolded Protein Response
Regulation of the Unfolded Protein Response
Bacterial Protein Maturation
Regulation of Nuclear Protein Sorting
Directing Proteins to the Rough Endoplasmic Reticulum
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...

